Search

Anne L. Holleran

Examiner (ID: 14328, Phone: (571)272-0833 , Office: P/1642 )

Most Active Art Unit
1642
Art Unit(s)
1642, 1643
Total Applications
775
Issued Applications
297
Pending Applications
125
Abandoned Applications
356

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5278530 [patent_doc_number] => 20090130662 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'Method for Diagnosis of Prostate Cancer' [patent_app_type] => utility [patent_app_number] => 11/886263 [patent_app_country] => US [patent_app_date] => 2006-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10538 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20090130662.pdf [firstpage_image] =>[orig_patent_app_number] => 11886263 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/886263
Method for Diagnosis of Prostate Cancer Mar 13, 2006 Abandoned
Array ( [id] => 5693712 [patent_doc_number] => 20060153859 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-13 [patent_title] => 'Ganglioside-KLH conjugate vaccine with QS-21' [patent_app_type] => utility [patent_app_number] => 11/375549 [patent_app_country] => US [patent_app_date] => 2006-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 32681 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20060153859.pdf [firstpage_image] =>[orig_patent_app_number] => 11375549 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/375549
Ganglioside-KLH conjugate vaccine with QS-21 Mar 12, 2006 Abandoned
10/031722 Human monoclonal antibodies to her2/neu Mar 5, 2006 Abandoned
Array ( [id] => 5403506 [patent_doc_number] => 20090238820 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-24 [patent_title] => 'ANTI-MAdCAM ANTIBODY COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 11/815259 [patent_app_country] => US [patent_app_date] => 2006-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 28259 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0238/20090238820.pdf [firstpage_image] =>[orig_patent_app_number] => 11815259 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/815259
ANTI-MAdCAM ANTIBODY COMPOSITIONS Mar 1, 2006 Abandoned
Array ( [id] => 5666602 [patent_doc_number] => 20060171952 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-03 [patent_title] => 'JAM-3 and antibodies that bind thereto' [patent_app_type] => utility [patent_app_number] => 11/347057 [patent_app_country] => US [patent_app_date] => 2006-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 24273 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20060171952.pdf [firstpage_image] =>[orig_patent_app_number] => 11347057 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/347057
JAM-3 and antibodies that bind thereto Feb 1, 2006 Abandoned
Array ( [id] => 5349310 [patent_doc_number] => 20090004671 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-01 [patent_title] => 'Marker Protein For Use In Diagnosis Of Pancreatic Cancer' [patent_app_type] => utility [patent_app_number] => 11/908694 [patent_app_country] => US [patent_app_date] => 2006-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 5832 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20090004671.pdf [firstpage_image] =>[orig_patent_app_number] => 11908694 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/908694
Marker Protein For Use In Diagnosis Of Pancreatic Cancer Jan 25, 2006 Abandoned
Array ( [id] => 8176240 [patent_doc_number] => 08178102 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-15 [patent_title] => 'Emulsified composition for dilution and cancer vaccine composition' [patent_app_type] => utility [patent_app_number] => 11/814270 [patent_app_country] => US [patent_app_date] => 2006-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 12042 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/178/08178102.pdf [firstpage_image] =>[orig_patent_app_number] => 11814270 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/814270
Emulsified composition for dilution and cancer vaccine composition Jan 18, 2006 Issued
Array ( [id] => 4792160 [patent_doc_number] => 20080293134 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'Human Cancer Suppressor Gene, Protein Encoded Therein, Expression Vector Containing Same' [patent_app_type] => utility [patent_app_number] => 11/794430 [patent_app_country] => US [patent_app_date] => 2005-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 55 [patent_no_of_words] => 41694 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20080293134.pdf [firstpage_image] =>[orig_patent_app_number] => 11794430 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/794430
Human Cancer Suppressor Gene, Protein Encoded Therein, Expression Vector Containing Same Dec 27, 2005 Abandoned
Array ( [id] => 4960036 [patent_doc_number] => 20080274461 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-06 [patent_title] => 'Perinucleolar Compartment Markers for Cancer' [patent_app_type] => utility [patent_app_number] => 11/794346 [patent_app_country] => US [patent_app_date] => 2005-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9802 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20080274461.pdf [firstpage_image] =>[orig_patent_app_number] => 11794346 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/794346
Perinucleolar Compartment Markers for Cancer Dec 21, 2005 Abandoned
Array ( [id] => 5776308 [patent_doc_number] => 20060104948 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-18 [patent_title] => 'Interferon immunotherapy' [patent_app_type] => utility [patent_app_number] => 11/314227 [patent_app_country] => US [patent_app_date] => 2005-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5842 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20060104948.pdf [firstpage_image] =>[orig_patent_app_number] => 11314227 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/314227
Interferon immunotherapy Dec 20, 2005 Abandoned
Array ( [id] => 4812830 [patent_doc_number] => 20080193461 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-14 [patent_title] => 'Use of Angiopoietins in Tumor Therapy' [patent_app_type] => utility [patent_app_number] => 11/793452 [patent_app_country] => US [patent_app_date] => 2005-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 17734 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20080193461.pdf [firstpage_image] =>[orig_patent_app_number] => 11793452 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/793452
Use of Angiopoietins in Tumor Therapy Dec 19, 2005 Abandoned
Array ( [id] => 4676129 [patent_doc_number] => 20080213759 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'Novel Angiogenesis Inhibitor' [patent_app_type] => utility [patent_app_number] => 11/722799 [patent_app_country] => US [patent_app_date] => 2005-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16187 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20080213759.pdf [firstpage_image] =>[orig_patent_app_number] => 11722799 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/722799
Novel Angiogenesis Inhibitor Dec 19, 2005 Abandoned
Array ( [id] => 4758890 [patent_doc_number] => 20080311116 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'Process for the Determination of Inflammatory Process and Pharmaceutical Compositions for the Treatment Thereof' [patent_app_type] => utility [patent_app_number] => 11/792677 [patent_app_country] => US [patent_app_date] => 2005-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13712 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20080311116.pdf [firstpage_image] =>[orig_patent_app_number] => 11792677 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/792677
Process for the determination of inflammatory processes and pharmaceutical compositions for the treatment thereof Dec 12, 2005 Issued
Array ( [id] => 5872968 [patent_doc_number] => 20060165703 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Methods and compositions useful for inhibition of alpha v beta 5 mediated angiogenesis' [patent_app_type] => utility [patent_app_number] => 11/290896 [patent_app_country] => US [patent_app_date] => 2005-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 35022 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20060165703.pdf [firstpage_image] =>[orig_patent_app_number] => 11290896 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/290896
Methods and compositions useful for inhibition of alpha v beta 5 mediated angiogenesis Nov 28, 2005 Abandoned
Array ( [id] => 4971266 [patent_doc_number] => 20070111268 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-17 [patent_title] => 'Methods, compositions and kits for use in prognosis, characterization and treatment of cancer' [patent_app_type] => utility [patent_app_number] => 11/273184 [patent_app_country] => US [patent_app_date] => 2005-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 20425 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20070111268.pdf [firstpage_image] =>[orig_patent_app_number] => 11273184 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/273184
Methods, compositions and kits for use in prognosis, characterization and treatment of cancer Nov 13, 2005 Abandoned
Array ( [id] => 6594662 [patent_doc_number] => 20100062426 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'AGR2 and TFF3 Regulation in the Diagnosis and Treatment of Cancer' [patent_app_type] => utility [patent_app_number] => 12/092626 [patent_app_country] => US [patent_app_date] => 2005-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 1774 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20100062426.pdf [firstpage_image] =>[orig_patent_app_number] => 12092626 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/092626
AGR2 and TFF3 Regulation in the Diagnosis and Treatment of Cancer Nov 2, 2005 Abandoned
Array ( [id] => 4663545 [patent_doc_number] => 20080254452 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-16 [patent_title] => 'Pkp3 Oncogene as a Prognostic Indicator for Lung Cancer' [patent_app_type] => utility [patent_app_number] => 11/577485 [patent_app_country] => US [patent_app_date] => 2005-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4236 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20080254452.pdf [firstpage_image] =>[orig_patent_app_number] => 11577485 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/577485
PKP3 oncogene as a prognostic indicator for lung cancer Oct 17, 2005 Issued
Array ( [id] => 348958 [patent_doc_number] => 07495074 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-24 [patent_title] => 'Isolated proteins MAGE-4 and MAGE-41' [patent_app_type] => utility [patent_app_number] => 11/253240 [patent_app_country] => US [patent_app_date] => 2005-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 20 [patent_no_of_words] => 16456 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/495/07495074.pdf [firstpage_image] =>[orig_patent_app_number] => 11253240 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/253240
Isolated proteins MAGE-4 and MAGE-41 Oct 16, 2005 Issued
Array ( [id] => 4866310 [patent_doc_number] => 20080145369 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-19 [patent_title] => 'Autocrine Growth Factor Receptors and Methods' [patent_app_type] => utility [patent_app_number] => 11/665359 [patent_app_country] => US [patent_app_date] => 2005-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 4882 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0145/20080145369.pdf [firstpage_image] =>[orig_patent_app_number] => 11665359 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/665359
Autocrine Growth Factor Receptors and Methods Oct 11, 2005 Abandoned
Array ( [id] => 177923 [patent_doc_number] => 07655631 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-02 [patent_title] => 'Pharmaceutical preparations and methods for inhibiting tumors' [patent_app_type] => utility [patent_app_number] => 11/240937 [patent_app_country] => US [patent_app_date] => 2005-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 34 [patent_no_of_words] => 25522 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/655/07655631.pdf [firstpage_image] =>[orig_patent_app_number] => 11240937 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/240937
Pharmaceutical preparations and methods for inhibiting tumors Sep 29, 2005 Issued
Menu